Coronavirus disease (covid-19). Other coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: In this group, untreated COVID-19 patients are treated with routine treatments and 50,000 units of vitamin D daily for one week. Intervention 2: Intervention group:
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient was admitted to the acute respiratory center Consent to participate in the study Age 15 to above Do not take vitamin C and D supplements No gout Lack of kidney and liver disease No pregnancy or lactation No treatment with anti convulsants
Exclusion criteria
Exclusion criteria: The patient has lung cancer Patients undergoing chemotherapy and radiotherapy If the patient dies If the patient has a decreased level of consciousness If the patient does not want to continue working on the plan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete recovery of clinical symptoms of 2019 disease. Timepoint: About a week after starting treatment. Method of measurement: Clinical and laboratory questionnaire.;Normalization of chest symptoms in CT scan. Timepoint: About 7 to 14 days after starting treatment. Method of measurement: CT scan result. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improving and normalizing the level of laboratory symptoms. Timepoint: At least 1 to 2 weeks after starting treatment. Method of measurement: Laboratory techniques. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEbrahim Shirzade
Sabzevar University of Medical Sciences
Outcome results
None listed